Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brett Braly

Orthopaedic Surgery of the Spine Oklahoma City, OK Medical Doctor

NPI 1750542056 CMS profile 306200

9800 Broadway Extension, Suite 201, Oklahoma City, OK 73114

Open in the dashboard

General payments

$278,948

375 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$116,846 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Brett Braly of Oklahoma City, OK is reported in the CMS Open Payments database as having received $278,948 across 375 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $116,846 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,295 20
2024 General $11,627 26
2023 General $48,070 42
2022 General $35,434 51
2021 General $94,165 91
2020 General $10,886 36
2019 General $66,471 109

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brett Braly
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Brett Braly were reported at $12,295. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Brett Braly Orthopaedic Surgery of the Spine median Middle half National median
2019 $66,471 $2,106 $337–$18,608 $163
2020 $10,886 $1,213 $156–$15,082 $114
2021 $94,165 $1,834 $271–$15,617 $132
2022 $35,434 $2,015 $320–$17,036 $149
2023 $48,070 $1,925 $336–$14,599 $160
2024 $11,627 $2,110 $341–$12,483 $164
2025 $12,295 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $191,253 225 payments
  2. NuVasive, Inc. $65,252 86 payments
  3. VB Spine LLC $11,087 13 payments
  4. Kuros Biosciences USA, Inc $7,915 9 payments
  5. Globus Medical, Inc. $1,341 7 payments
  6. MML US, Inc. $763 3 payments
  7. Alphatec Spine, Inc $452 3 payments
  8. Spinal Elements, Inc. $227 2 payments
  9. Abbott Laboratories $183 14 payments
  10. Centinel Spine, LLC $172 1 payment
  11. Other $304 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $206,895 60 payments
  2. Travel and Lodging $48,948 137 payments
  3. Food and Beverage $10,415 174 payments
  4. Royalty or License $8,000 1 payment
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,200 1 payment
  6. Education $1,489 2 payments
Products named General payments · program years 2019–2025
  1. RAVINE LATERAL ACCESS SYSTEM $59,576 21 payments
  2. NIAGARA LATERAL ACCESS SYSTEM $53,728 23 payments
  3. XLIF $44,594 22 payments
  4. CASCADIA INTERBODY SYSTEM $34,288 52 payments
  5. ALIF $25,016 14 payments
  6. TRITANIUM $24,351 6 payments
  7. ES2 SPINAL SYSTEM $17,135 9 payments
  8. AIRO $15,247 5 payments
  9. LATERAL ACCESS SPINAL SYSTEM $8,500 2 payments
  10. Vulcan Spinal System $8,452 6 payments
  11. Other $36,577 171 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

521

Median for Orthopedic Surgery: 203

Drug cost

$6,348

Median for Orthopedic Surgery: $1,433

Branded share of claims

56.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 178 $2,754
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 117 $1,770
Tizanidine Hcl Generic 156 $1,245
Gabapentin Generic 44 $338
Hydromorphone Hcl Generic 13 $150
Tramadol Hcl Generic 13 $91

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$223,103

Of which drugs: $27

Medicare patients

216

Average age 72

Services billed

936

106 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 38%
Diabetes 30%
Depression 29%
Chronic kidney disease 23%
COPD 19%
Osteoporosis 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
PROLATE
  • Forte Bio-Pharma LLC $64
$64 — —
NALOCET
  • Forte Bio-Pharma LLC $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

375 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record